Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cutaneous and Systemic Findings Associated With Nuclear Matrix Protein 2 Antibodies in Adult Dermatomyositis Patients.

Arthritis care & research - 1 Dec 2017

Rogers Anna, Chung Lorinda, Li Shufeng, Casciola-Rosen Livia, Fiorentino David F

Abstract excerpt

OBJECTIVE: To characterize the cutaneous and systemic clinical phenotype of dermatomyositis patients with antinuclear matrix protein 2 (anti-NXP-2) antibodies. METHODS: We conducted a retrospective cohort analysis of 178 dermatomyositis patients seen at the Stanford University Clinic. An electronic chart review employing a keyword search strategy was performed to collect clinical and laboratory data. Anti-NXP-2...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Antinuclear
Share to California

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Deglutition Disorders

Share to Dermatomyositis

Share to Myalgia

Share to Severity of Illness Index

Source

Open in PubMed Open full text

Identifiers

PMID: 28129490
DOI: 10.1002/acr.23210
PMCID: PMC5529261

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cutaneous and Systemic Findings Associated With Nuclear Matrix Protein 2 Antibodies in Adult Dermatomyositis Patients.PMID 28129490Read ↗

Anti-nuclear matrix protein 2 antibody-positive idiopathic inflammatory myopathies represent extensive myositis without dermatomyositis-specific rashSemantic proximity Read ↗

Antimelanoma Differentiation-associated Gene 5 Antibody: Expanding the Clinical Spectrum in North American Patients with Dermatomyositis.Semantic proximity Read ↗

Deep Pathological Phenotyping of Dermatomyositis with Different AutoantibodiesSemantic proximity Read ↗

Dermatomyositis With Anti-MDA5 Antibodies: Bioclinical Features, Pathogenesis and Emerging Therapies.Semantic proximity Read ↗

Association of NXP2 autoantibodies with a more severe clinical phenotype of juvenile dermatomyositis.Semantic proximity Read ↗

Anti-melanoma differentiation-associated 5 gene antibody-positive dermatomyositis exhibit three clinical phenotypes with different prognoses.Semantic proximity Read ↗

Prevalence and clinical significance of anti-MDA5 antibodies in European patients with polymyositis/dermatomyositis.Semantic proximity Read ↗

Identification of clinical features and autoantibodies associated with calcinosis in dermatomyositis.Semantic proximity Read ↗

Clinical phenotype and prognostic determinants of spontaneous pneumomediastinum in anti-MDA5 antibody-positive dermatomyositis.Semantic proximity Read ↗

A retrospective study for clinical characteristics of 293 patients with dermatomyositis.Semantic proximity Read ↗

Case Report: Anti-MDA-5 dermatomyositis in a resource-limited settingSemantic proximity Read ↗

Distinctive cutaneous and systemic features associated with specific antimyositis antibodies in adults with dermatomyositis: a prospective multicentric study of 117 patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.